Articles related to BUSINESS & POLICY

The ASHP’s newly revised guidelines offer actionable steps for community pharmacies to combat controlled substance diversion, addressing both patient safety and regulatory compliance.

Stay abreast of the latest trends in psychopharmacology, from the over-the-counter availability of Naloxone to the deadly rise of Xylazine and the ongoing tension between federal and state marijuana laws.

The alarming rise in physician suicides is a critical issue that demands immediate attention; explore the risk factors, warning signs, and what you can do to help.

The upcoming shift from HCC Version 24 to Version 28 poses serious implications for oncology practices, particularly in how they report patient complexity. A proactive approach is essential to navigate these sweeping changes effectively.

Discover how evidence-informed policy making can revolutionize oral health systems and why now is the opportune moment for dental professionals to engage in this transformative process.

Learn how the termination of USAID’s DEEP VZN program could signal a shift in global health priorities, emphasizing the importance of disease surveillance and biosecurity over speculative virus hunting.